Published in J Neurodev Disord on May 21, 2010
Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications. Am J Med Genet B Neuropsychiatr Genet (2012) 0.94
Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alström syndromes. Adv Genomics Genet (2015) 0.80
The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science (2005) 4.54
Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med (2005) 2.04
Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics (2004) 1.81
Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics (2006) 1.36
Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet (1997) 1.35
Psychiatric disorders in Prader-Willi syndrome: epidemiology and management. CNS Drugs (2003) 1.12
Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol Psychiatry (2007) 1.09
Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol (2000) 1.09
Functional characterization of the human TPH2 5' regulatory region: untranslated region and polymorphisms modulate gene expression in vitro. Hum Genet (2007) 1.08
Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond) (2008) 1.05
TPH2 and TPH1: association of variants and interactions with heroin addiction. Behav Genet (2008) 1.04
The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res (2007) 1.03
Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment Retard Dev Disabil Res Rev (2000) 0.90
Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biol Psychiatry (1998) 0.83
Nutritional phases in Prader-Willi syndrome. Am J Med Genet A (2011) 2.08
Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med (2005) 2.04
Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A (2008) 1.96
Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet (2011) 1.94
Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity (Silver Spring) (2009) 1.88
Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics (2004) 1.81
Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Genet A (2007) 1.51
Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A (2007) 1.40
Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics (2006) 1.36
Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) (2006) 1.30
X chromosome gene expression in human tissues: male and female comparisons. Genomics (2006) 1.26
Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res (2008) 1.21
Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients. Am J Med Genet A (2007) 1.16
Do known mutations in neuroligin genes (NLGN3 and NLGN4) cause autism? J Autism Dev Disord (2004) 1.14
ANKRD11 gene deletion in a 17-year-old male. Clin Dysmorphol (2011) 1.09
Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Genet Test (2007) 1.07
Gene expression in cardiac tissues from infants with idiopathic conotruncal defects. BMC Med Genomics (2011) 1.07
snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions. Gene (2007) 1.07
Validation of the Agilent 244K oligonucleotide array-based comparative genomic hybridization platform for clinical cytogenetic diagnosis. Am J Clin Pathol (2009) 1.07
Gastric rupture and necrosis in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr (2007) 1.06
Whole genome microarray analysis of gene expression in Prader-Willi syndrome. Am J Med Genet A (2007) 1.06
Noncoding RNA expression in myocardium from infants with tetralogy of Fallot. Circ Cardiovasc Genet (2012) 1.05
Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome. Am J Med Genet A (2005) 1.04
Whole genome microarray analysis of gene expression in subjects with fragile X syndrome. Genet Med (2007) 1.04
A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis. Am J Med Genet A (2006) 1.03
Newborn with anophthalmia and features of Fryns syndrome. Pediatr Dev Pathol (2002) 1.00
Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. J Pediatr Endocrinol Metab (2004) 0.98
Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg (2005) 0.98
Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity (Silver Spring) (2006) 0.96
Mass Screening for Severe Problem Behavior among Infants and Toddlers In Peru. J Ment Health Res Intellect Disabil (2012) 0.96
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. Arch Pathol Lab Med (2006) 0.95
A clinical report and further delineation of the 14q32 deletion syndrome. Clin Dysmorphol (2011) 0.95
Risk factors for self-injury, aggression, and stereotyped behavior among young children at risk for intellectual and developmental disabilities. Am J Intellect Dev Disabil (2014) 0.94
Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. Genomics (2005) 0.93
A 15q13.3 homozygous microdeletion associated with a severe neurodevelopmental disorder suggests putative functions of the TRPM1, CHRNA7, and other homozygously deleted genes. Am J Med Genet A (2010) 0.91
Quantitative real-time polymerase chain reaction for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet Test Mol Biomarkers (2009) 0.91
X-chromosome inactivation patterns in females with Prader-Willi syndrome. Am J Med Genet A (2007) 0.91
Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management. Lipids Health Dis (2011) 0.90
Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome. Am J Med Genet A (2007) 0.89
Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Curr Genomics (2011) 0.89
IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. Eur J Med Genet (2011) 0.85
Deaths due to choking in Prader-Willi syndrome. Am J Med Genet A (2007) 0.84
The neuroanatomy of genetic subtype differences in Prader-Willi syndrome. Am J Med Genet B Neuropsychiatr Genet (2012) 0.84
A clinical case report and literature review of the 3q29 microdeletion syndrome. Clin Dysmorphol (2015) 0.83
An 18-year follow-up report on an infant with a duplication of 9q34. Am J Med Genet A (2010) 0.83
Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome. Int J Mol Med (2005) 0.82
Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence. Drug Alcohol Depend (2013) 0.81
1.39 Mb inherited interstitial deletion in 12p13.33 associated with developmental delay. Eur J Med Genet (2010) 0.81
Drowning as a cause of death in Angelman syndrome. Am J Ment Retard (2002) 0.81
Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome. Genet Test Mol Biomarkers (2011) 0.80
Eye abnormalities in Fryns syndrome. Am J Med Genet A (2004) 0.80
Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia. Obesity (Silver Spring) (2014) 0.80
X chromosome inactivation in women with alcoholism. Alcohol Clin Exp Res (2012) 0.80
Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome. Eur J Hum Genet (2013) 0.80
TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome. J Child Psychol Psychiatry (2011) 0.80
Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. J Child Adolesc Psychopharmacol (2015) 0.79
Apo lipoprotein A1 gene polymorphisms predict cardio-metabolic risk in South Asian immigrants. Dis Markers (2012) 0.79
APOA1 gene polymorphisms in the South Asian immigrant population in the United States. Indian J Hum Genet (2011) 0.79
Expanding the phenotype of SPONASTRIME dysplasia to include short dental roots, hypogammaglobulinemia, and cataracts. Am J Med Genet A (2008) 0.79
12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes. Clin Dysmorphol (2012) 0.79
Comparison of biological specimens and DNA collection methods for PCR amplification and microarray analysis. Clin Chem Lab Med (2013) 0.79
Development and implementation of electronic growth charts for infants with Prader-Willi syndrome. Am J Med Genet A (2012) 0.79
Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J Clin Invest (2016) 0.79
Clonality studies in sacral chordoma. Cancer Genet Cytogenet (2006) 0.79
Oculoauriculofrontonasal syndrome (OAFNS) in a nine-month-old male. Am J Med Genet (2002) 0.79
Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome. Am J Med Genet A (2008) 0.78
Exon microarray analysis of human dorsolateral prefrontal cortex in alcoholism. Alcohol Clin Exp Res (2014) 0.78
Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization. Am J Med Genet A (2008) 0.77
Genomics of childhood obesity. Curr Genomics (2011) 0.77
An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype. Am J Med Genet A (2010) 0.77
Deletion of TOP3B Is Associated with Cognitive Impairment and Facial Dysmorphism. Cytogenet Genome Res (2016) 0.76
C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med (2006) 0.76
Genome-wide linkage and copy number variation analysis reveals 710 kb duplication on chromosome 1p31.3 responsible for autosomal dominant omphalocele. J Med Genet (2012) 0.75
14q32 deletion syndrome: a clinical report. Clin Dysmorphol (2012) 0.75
Letter to the editor: Long-term experience with duodenal switch in adolescents. Obes Surg (2012) 0.75
Marshall-Smith syndrome: Follow-up report of a four and a half year old male. Am J Med Genet A (2004) 0.75
45,X/46,XY mosaicism and fragile X syndrome. Am J Med Genet A (2003) 0.75
Laparoscopic sleeve gastrectomy in 108 obese children and adolescents ages 5 to 21 years by Alqahtani AR, Antonisamy B, Alamri H, Elahmedi M, Zimmerman VA. Ann Surg (2015) 0.75
GENETIC AND OTHER HEALTH PROBLEMS ASCERTAINED IN FAMILIES OF THE DAUGHTERS OF THE AMERICAN REVOLUTION. Dysmorphol Clin Genet (1991) 0.75
Distal Partial Trisomy 15q26 and Partial Monosomy 16p13.3 in a 36-Year-Old Male with Clinical Features of Both Chromosomal Abnormalities. Cytogenet Genome Res (2015) 0.75
Prader-Willi Syndrome due to an Unbalanced de novo Translocation t(15;19)(q12;p13.3). Cytogenet Genome Res (2016) 0.75
Progress in pediatric cardiology ("Genetics of Pediatric Heart Disease"). Prog Pediatr Cardiol (2005) 0.75